Clinical Trials Browser

Phase 3 × HER2-positive Advanced Breast Cancer × Trastuzumab × Clear all

NCT05901935 2023-06-13

DP303c in Patients With HER2-positive Advanced Breast Cancer

Phase 3 Not yet recruiting

HER2-positive Advanced Breast Cancer